# Paul Blanchfield

> Paul Blanchfield is the CEO of Alpha-9 Oncology, a Boston-based clinical-stage radiopharmaceutical company developing targeted alpha and beta therapies for cancer. He took the top job in November 2025 after running Lantheus as President, following earlier operator stints at Takeda and Shire and a five-year run at McKinsey.

- **Role:** Chief Executive Officer at Alpha-9 Oncology
- **Organizations:** Alpha-9 Oncology, Lantheus, Takeda, Shire Pharmaceuticals, McKinsey & Company
- **Nationality:** American
- **Education:** BA in Economics, Duke University, MBA and MA in Education, Stanford University
- **Known for:** Rose to President of Lantheus, one of the largest independent radiopharmaceutical companies, Ran a P&L as General Manager for Nordics-Baltics at Shire/Takeda, Named CEO of Alpha-9 Oncology in the wake of its $175M Series C led by Lightspeed and Ascenta

## Career timeline

- **pre-2013** — Consultant at McKinsey & Company, serving pharmaceutical and healthcare clients (approx. five years)
- **2013-2019** — Executive roles at Shire and Takeda, including Chief of Staff to the CEO, Head of Corporate Strategy, General Manager Nordics-Baltics, and Head of U.S. Immunology
- **2019-2025** — Senior leadership at Lantheus, culminating in President, overseeing Commercial, R&D, Medical, Technical Operations and Quality
- **2025-11** — Appointed CEO and Board member of Alpha-9 Oncology

## Achievements

- Rose to President of Lantheus, one of the largest independent radiopharmaceutical companies
- Ran a P&L as General Manager for Nordics-Baltics at Shire/Takeda
- Named CEO of Alpha-9 Oncology in the wake of its $175M Series C led by Lightspeed and Ascenta
- Held Chief of Staff to the CEO at Shire, one of the more coveted seat-next-to-power roles in pharma

## Latest updates

- **2025-11** — Appointed Chief Executive Officer and Board member of Alpha-9 Oncology.
- **2024-10** — Alpha-9 closed a $175M Series C led by Lightspeed Venture Partners and Ascenta Capital (context, prior to his appointment).

## Links

- Website: https://a9oncology.com
- LinkedIn: https://www.linkedin.com/in/pblanchfield

---

Profile page: https://yespress.io/paul-blanchfield
Published by YesPress — https://yespress.io
Last updated: 2026-07-09